Apricus Biosciences (APRI) Announces Appointment Of Wendell Wierenga, Ph.D., To Board Of Directors
3/10/2014 9:40:54 AM
SAN DIEGO, March 10, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), today announced the appointment of Wendell Wierenga, Ph.D., to the Company's Board of Directors. Dr. Wierenga brings decades of experience heading research and development programs that led to the marketing approval of over 15 medicines and has participated in the filing of over 70 Investigational New Drug (IND) disclosures. His appointment is effective immediately.
Help employers find you! Check out all the jobs and post your resume.
comments powered by